Damora Therapeutics, Inc. (DMRA)
$18.43-0.70%Close
SELLCRISIS · day 22
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.1B
- Beta
- 1.44
- P/E (TTM)
- -0.15
- Short % float
- 11.48%
- Days to cover
- 4.8
- SI change
- +0.0%
- 1W
- -8.94%
- 1M
- -25.54%
- vs SPY 1W
- -8.80%
- vs SPY 1M
- -28.04%
Industry peers
FMP comparable companies · ranked by market cap
- GMABBUYGenmab A/S$22.5BBULLQ 21$36.57+0.88%
- INCYSELLIncyte Corporation$22.0BBEARQ 13$108.62+2.72%
- IRONSELLDisc Medicine, Inc.$2.2BCRISISQ 0$56.60-1.52%
- QURESELLuniQure N.V.$1.5BCRISISQ 16$21.28-1.46%
- COAGSELLHemab Therapeutics Holdings, Inc. Common Stock$1.4BQ -10$29.80+0.47%
- RIGLBUYRigel Pharmaceuticals, Inc.$872MBEARQ 9$47.14-0.68%
- GERNSELLGeron Corporation$770MRECOVERYQ 11$1.20-0.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 5
- GROWTH
- 39
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-49.5%
REV YoY-
ROE-82.6%
EPS YoY-
ROA-48.3%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.15
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B2.18
P/FCF-
EV/EBITDA-2.24
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO19.73
ND/EBITDA-
BETA1.44
Company news
FAQ
- What is LOPJLB’s current signal on DMRA?
- LOPJLB’s latest quantitative signal on Damora Therapeutics, Inc. (DMRA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is DMRA in?
- Damora Therapeutics, Inc. (DMRA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Damora Therapeutics, Inc. (DMRA) do?
- Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The companyâs lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent …